Peer Review History

Original SubmissionOctober 20, 2023
Decision Letter - Yung-Hsiang Chen, Editor

PONE-D-23-34488Efficacy and safety of acupuncture treatment for post-stroke depression:A protocol for systematic review and meta-analysisPLOS ONE

Dear Dr. Zou,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Thank you for submitting the following manuscript to PLOS ONE.Please revise the manuscript according to the reviewers' comments and upload the revised file.==============================

Please submit your revised manuscript by Feb 17 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yung-Hsiang Chen, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please clarify the search dates, as your manuscript states both 'until September 2023' and 'to September 20, 2024

3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

5. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

Additional Editor Comments:

Thank you for submitting the following manuscript to PLOS ONE.

Please revise the manuscript according to the reviewers' comments and upload the revised file.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: No

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. This study failed to state why it is important to do this review. Several meta-analyses/protocols of meta-analysis have been published in recent years. However, there is no effective comparison between the previous meta-analysis and this one in the background or discussion.

2. The author needs to improve the English expression and grammar of the full text.

3. The total effective rate of AC to treat PSD was selected as the primary outcome in this study, but the author failed to state the definition of effective.

4. The protocol of data synthesis and Sensitivity analysis needs to be more detailed.

Reviewer #2: The manuscript, presenting a research protocol for a meta-analysis on the effectiveness and safety of acupuncture therapy in treating post-stroke depression, appears to be of good quality. The topic chosen is of considerable clinical significance. Although the initial quality of the manuscript is commendable, there are areas where further refinement could enhance its scientific rigor and clarity. Detailed observations and suggestions are provided below to assist in these potential improvements.

1. Innovativeness

Your manuscript mentions previous similar meta-analyses and describes their limitations. This is a good starting point. To strengthen the innovativeness of your manuscript, it is suggested to more elaborately detail how this study makes innovative contributions on this basis, and the importance of these innovations in the current field of research.

2. Structure of the Abstract

The abstract is a crucial part of the paper, aiming to concisely and clearly highlight the main points of the research. Regarding the background section, it is advised to streamline the current expression, retaining only information directly relevant to the research, to enhance the clarity and efficiency of the abstract.

3. Tense Issues

In lines 173 to 175, you refer to the characteristics of this study as a protocol. Regarding the use of tense, it is recommended to review and adjust to ensure consistency and accuracy in the text when describing the research design, methods, and expected outcomes.

4. Choice of SMD

When choosing the Standardized Mean Difference (SMD) as the measure of effect size, please provide a more detailed explanation as to why the Mean Difference (MD) is not applicable in this study.

5. Introduction to GRADE

In lines 188 to 190, the introduction to the GRADE assessment method seems overly brief. To better help readers understand how you have applied this method and its role in your research, please provide a more detailed explanation, including its assessment criteria and how it is applied in this study.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editors and Reviewers:

Thank you for your letter and for the reviewers' comments concerning our manuscript entitled “Efficacy and safety of acupuncture treatment for post-stroke depression: A protocol for systematic review and meta-analysis” (PONE-D-23-34488). Those comments are all valuable and very helpful for revising and improving our paper. We have studied comments carefully and have made correction which we hope meet with approval. And All changes made in the revised manuscript have been marked in red text. Major corrections in the paper and responses to editorial and reviewer comments follow:

Journal Requirements:

1)Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Reply: The paper has been modified according to the journal format requirements.

2)Please clarify the search dates, as your manuscript states both 'until September 2023' and 'to September 20, 2024'.

Reply: Thank you for pointing out the issue. After careful consideration of the entire text, we have removed the section 'to September 20, 2024' for greater clarity.

3)Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

Reply: Provided .

4)PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

Reply: The ORCID iD of the corresponding author has been added to 'Update my Information'.

5)We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

Reply: Changes have been made.

Reviewer #1: 

1)This study failed to state why it is important to do this review. Several meta-analyses/protocols of meta-analysis have been published in recent years. However, there is no effective comparison between the previous meta-analysis and this one in the background or discussion.

Reply: Currently, oral antidepressants such as selective serotonin reuptake inhibitors (SSRIs), norepinephrine reuptake inhibitors (SNRIs), and norepinephrine and dopamine reuptake inhibitors (NDRIs) are commonly used in clinical practice. However, the effectiveness and safety of treating post-stroke depression (PSD) using these antidepressants are still controversial. It is important to consider the patient's underlying condition, compliance, and potential adverse reactions to antidepressant drugs. Evaluating the clinical treatment effect can be challenging. Long-term use of SSRI antidepressants has been associated with an increased risk of stroke, myocardial infarction, and all-cause mortality. In contrast, acupuncture, known as a 'green therapy,' has been proven effective and safe in treating PSD. Acupuncture utilizes the advantages of Traditional Chinese Medicine (TCM) syndrome differentiation and treatment, while also reducing the side effects of Western medicine. It can improve patients' negative mood, alleviate somatic symptoms, and promote neurological function recovery. Therefore, studying the effectiveness of acupuncture treatment for PSD is of great significance, and the significance of the study is explained in the revised manuscript.

2)The author needs to improve the English expression and grammar of the full text.

Reply: Thanks for your suggestion. We have tried our best to polish the language in the revised manuscript. These changes will not influence the content and framework of the paper.

3)The total effective rate of AC to treat PSD was selected as the primary outcome in this study, but the author failed to state the definition of effective.

Reply: As suggested by the reviewer, we have added a definition of total effective rate in the Type of outcome measures section and highlighted it in red text.

4)The protocol of data synthesis and Sensitivity analysis needs to be more detailed.

Reply: Thanks for your suggestion. Data synthesis and Sensitivity analysis have been described in more detail.

Reviewer #2: The manuscript, presenting a research protocol for a meta-analysis on the effectiveness and safety of acupuncture therapy in treating post-stroke depression, appears to be of good quality. The topic chosen is of considerable clinical significance. Although the initial quality of the manuscript is commendable, there are areas where further refinement could enhance its scientific rigor and clarity. Detailed observations and suggestions are provided below to assist in these potential improvements.

1) Innovativeness

Your manuscript mentions previous similar meta-analyses and describes their limitations. This is a good starting point. To strengthen the innovativeness of your manuscript, it is suggested to more elaborately detail how this study makes innovative contributions on this basis, and the importance of these innovations in the current field of research.

Reply: TCM believes that PSD is an emotional disease that occurs on the basis of stroke due to a variety of reasons that lead to emotional disorders, which always belongs to the category of "depression due to illness". After a stroke, patients' motor function of the limbs, language and thinking ability and cognitive function will be damaged to varying degrees, which results in the gradual decline of the patients' ability to take care of themselves in their daily life and their ability to socialize, as well as the marginalization of society. As a result, the patient's self-care ability in daily life, social ability and social marginalization are gradually reduced, leading to symptoms such as being sentimental, having a bad mood, being depressed, and being lazy and less active. Acupuncture utilizes the advantages of TCM syndrome differentiation and treatment, while also reducing the side effects of Western medicine. It can improve patients' negative mood, alleviate somatic symptoms, and promote neurological function recovery. Therefore, studying the effectiveness of acupuncture treatment for PSD is of great significance, and the significance of the study is explained in the revised manuscript.

2) Structure of the Abstract

The abstract is a crucial part of the paper, aiming to concisely and clearly highlight the main points of the research. Regarding the background section, it is advised to streamline the current expression, retaining only information directly relevant to the research, to enhance the clarity and efficiency of the abstract.

Reply: Thanks for your suggestion. Abstracts have been streamlined to better highlight the main points of the paper's research.

3) Tense Issues

In lines 173 to 175, you refer to the characteristics of this study as a protocol. Regarding the use of tense, it is recommended to review and adjust to ensure consistency and accuracy in the text when describing the research design, methods, and expected outcomes.

Reply: We feel sorry for our carelessness. In our resubmitted manuscript, the tense issues in the subgroup analysis section has been revised. Thanks for your correction.

4) Choice of SMD

When choosing the Standardized Mean Difference (SMD) as the measure of effect size, please provide a more detailed explanation as to why the Mean Difference (MD) is not applicable in this study.

Reply: After gaining an in-depth understanding of the definitions of SMD and MD, we believe that this study should use MD as a measure of effect size. At the same time, it is stated in the revised manuscript that if different measurement tools are used for the same variables, SMD will be used for analysis. Thank you for your correction, which allowed us to make timely adjustments to the statistical methods of the protocol.

5) Introduction to GRADE

In lines 188 to 190, the introduction to the GRADE assessment method seems overly brief. To better help readers understand how you have applied this method and its role in your research, please provide a more detailed explanation, including its assessment criteria and how it is applied in this study.

Reply: Thank you for your suggestion. We have provided a more detailed explanation of the GRADE evaluation method, evaluation criteria, and its application in this study in the revised manuscript.

We tried our best to improve the manuscript and made some changes in the manuscript.

We appreciate for Editors and Reviewers' warm work earnestly, and hope that the correction will meet with approval. Once again thank you very much for your comments and suggestions.

Yours sincerely,

Wei Zou

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Yung-Hsiang Chen, Editor

Efficacy and safety of acupuncture treatment for post-stroke depression:A protocol for systematic review and meta-analysis

PONE-D-23-34488R1

Dear Dr. Zou,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yung-Hsiang Chen, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Your manuscript has been evaluated by external reviewers and members of the editorial board.

Congratulations on the acceptance of your manuscript, and thank you for your interest in submitting your work to PLOS ONE.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #3: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #3: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #3: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The paper discusses the high incidence and low recognition rate of post-stroke depression (PSD), emphasizing its impact on patients’ mental well-being and the increased risk of stroke recurrence and poor prognosis. It highlights the public health concern posed by PSD. It examines the popularity and inconsistent clinical research results regarding the efficacy and safety of acupuncture as a treatment for PSD. The systematic review aims to gather and critically assess all available evidence on the effectiveness and safety of acupuncture in treating patients with PSD. The authors address the journal’s requirements and reviewers’ comments, making corrections and providing clarifications to improve the manuscript. They emphasize the significance of studying acupuncture for PSD and detail their responses to the editorial and reviewer comments. This section serves as an introduction to the study protocol for a systematic review and meta-analysis on acupuncture treatment for PSD. It sets the stage for the detailed methodology and expected outcomes of the review. The manuscript has undergone a thorough review, and the revisions have been commendably executed. I advocate considering this manuscript for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Yung-Hsiang Chen, Editor

PONE-D-23-34488R1

PLOS ONE

Dear Dr. Zou,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yung-Hsiang Chen

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .